Keywords: progenics, gains, dehydroascorbate, license, pharmaceuticals, signed, licensing

Progenics gains dehydroascorbate license

Article | 29 March 1999

- Progenics Pharmaceuticals has signed a licensing agreement with theMemorial Sloan-Kettering Cancer Center for the exclusive worldwide right to use dehydroascorbic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Ascorbic Acid

Vitamin C

Go to drug listing